InVivo Biosystems
- Biotech or pharma, therapeutic R&D
InVivo Biosystems is developing novel RNA/oligo and gene therapeutics to support rare disease patients using our proprietary platform, RapidGen. We have active programs in DEE/epilepsy and Acidemia.
RapidGen drastically multiplies in vivo throughput using AI phenotyping and multiplexed delivery of CRISPR guide RNAs and oligomers, providing high-value target discovery in CNS, ophthalmology, and metabolic disease areas.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}